Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hyoscine hydrobromide 250micrograms/5ml oral solution
0406000L0AABJBJ
|
Hyoscine hydrobromide (Systemic) | Hyoscine hydrobromide | Central Nervous System | No data available |
|
Hyoscine hydrobromide 25micrograms/5ml oral solution
0406000L0AABIBI
|
Hyoscine hydrobromide (Systemic) | Hyoscine hydrobromide | Central Nervous System | No data available |
|
Hyoscine hydrobromide 2mg/5ml oral suspension
0406000L0AABLBL
|
Hyoscine hydrobromide (Systemic) | Hyoscine hydrobromide | Central Nervous System | No data available |
|
Hyoscine hydrobromide 3mg/5ml oral solution
0406000L0AAAZAZ
|
Hyoscine hydrobromide (Systemic) | Hyoscine hydrobromide | Central Nervous System | No data available |
|
Hyoscine hydrobromide 400micrograms/5ml oral solution
0406000L0AABGBG
|
Hyoscine hydrobromide (Systemic) | Hyoscine hydrobromide | Central Nervous System | No data available |
|
Hyoscine hydrobromide 600micrograms/5ml oral solution
0406000L0AABEBE
|
Hyoscine hydrobromide (Systemic) | Hyoscine hydrobromide | Central Nervous System | No data available |
|
Hyoscine hydrobromide 75micrograms/5ml oral solution
0406000L0AABHBH
|
Hyoscine hydrobromide (Systemic) | Hyoscine hydrobromide | Central Nervous System | No data available |
|
Hypafix gentle touch tape 15cm
20100000749
|
Hypafix gentle touch tape 15cm | Surgical Adhesive Tape | Dressings | No data available |
|
Hypafix gentle touch tape 2.5cm
20100000746
|
Hypafix gentle touch tape 2.5cm | Surgical Adhesive Tape | Dressings | No data available |
|
HYPER LYS Maxamaid powder
090401000BBDNA0
|
Proprietary compound foods for special diets | Other food for special diet preparations | Nutrition and Blood | No data available |
|
Hypnomidate 20mg/10ml solution for injection ampoules
1501010C0BBAAAA
|
Hypnomidate | Etomidate | Anaesthesia | No data available |
|
Hypnovel 10mg/5ml solution for injection ampoules
1501041T0BBAAAB
|
Hypnovel | Midazolam hydrochloride | Anaesthesia | No data available |
|
Hypodermic needle reusable size no 20 - 0.5mm/26gauge 13mm
21010900100
|
Hypodermic needle reusable size no 20 - 0.5mm/26gauge 13mm | Other Appliances | Appliances | No data available |
|
Hypodermic syringe ordinary purpose glass reusable 1ml
21010900310
|
Hypodermic syringe ordinary purpose glass reusable 1ml | Other Appliances | Appliances | No data available |
|
Hypodermic syringe ordinary purpose glass reusable 2ml
21010900320
|
Hypodermic syringe ordinary purpose glass reusable 2ml | Other Appliances | Appliances | No data available |
|
Hypoguard Supreme lancets 0.36mm/28gauge
21010900627
|
Hypoguard Supreme lancets 0.36mm/28gauge | Other Appliances | Appliances | No data available |
|
Hypoguard Supreme Spectrum testing strips
0601060D0BEACA0
|
Hypoguard (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Hypoguard Supreme testing strips
0601060D0BEABA0
|
Hypoguard (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Hypolar Retard 10mg tablets
0206020R0BQACAE
|
Hypolar | Nifedipine | Cardiovascular System | No data available |
|
Hypolar Retard 20 tablets
0206020R0BQAAAR
|
Hypolar | Nifedipine | Cardiovascular System | No data available |
|
Hypolar XL 30 tablets
0206020R0BQABAN
|
Hypolar | Nifedipine | Cardiovascular System | No data available |
|
Hypoloc 5mg tablets
0204000ABBCAAAA
|
Hypoloc | Nebivolol | Cardiovascular System | No data available |
|
Hypotears 1% eye drops
1108010Q0BDAAAB
|
Hypotears | Polyvinyl alcohol | Eye | No data available |
|
Hypovase 2mg tablets
0205040S0BBACAD
|
Hypovase | Prazosin hydrochloride | Cardiovascular System | No data available |
|
Hypovase tablets B.D. starter pack
0205040S0BBAEAA
|
Hypovase | Prazosin hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.